Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
David J. Kuter(Massachusetts General Hospital), James B. Bussel(NewYork–Presbyterian Hospital), Roger M. Lyons(Hematology Oncology Associates), Vinod Pullarkat(City of Hope), Terry Gernsheimer(Bloodworks Northwest), Francis M. Senecal(Northwest Medical Specialties), Louis M. Aledort(Mount Sinai Hospital), James N. George(University of Oklahoma Health Sciences Center), Craig M. Kessler(Georgetown University), Miguel Á. Sanz(Leitat Technological Center), Howard A. Liebman(Keck Hospital of USC), Frank T. Slovick(Hematology Oncology Associates), J. Th. M. de Wolf(University Medical Center Groningen), Emmanuelle Bourgeois(Hôpital Claude Huriez), Troy H. Guthrie(Baptist Cancer Center), Adrian C. Newland(Royal London Hospital), Jeffrey S. Wasser(Community Cancer Center), Solomon I. Hamburg(Tower Cancer Research Foundation), Carlos Grande(Research Institute Hospital 12 de Octubre), François Lefrère(Hôpital Necker-Enfants Malades), Alan Lichtin(Cleveland Clinic), Michael D. Tarantino(Bleeding & Clotting Disorders Institute), Howard R. Terebelo(Newland Medical Associates), Jean‐François Viallard(Hôpital Cardiologique du Haut-Lévêque), Francis J. Cuevas(Marshall University), Ronald S. Go(Gundersen Health System), David H. Henry(Illinois CancerCare), Robert L. Redner(UPMC Hillman Cancer Center), Lawrence Rice(Baylor College of Medicine), Martin R. Schipperus(Rijnland Ziekenhuis), Ding‐Ding Guo(Amgen (United States)), Janet L. Nichol(Amgen (United States))
Cited by 861
Abstract
Related Papers
No related papers found
Powered by citation graph analysis